美国颈动脉内膜剥脱术与支架置入术的固定及可变成本比较研究
基于Premier Perspective数据库2009年第三季度至2015年第一季度接受颈动脉内膜剥脱术(CEA)或颈动脉支架置入术(CAS)患者的出院和账单记录,经1:1倾向性评分匹配后,无症状队列25,812例(CEA 12,906例,CAS 12,906例)和有症状队列3,864例(CEA 1,932例,CAS 1,932例)纳入分析。结果显示,CAS的总住院成本在无症状患者中比CEA高40%(11,814美元 vs 8,378美元,P < .001),在有症状患者中高37%(19,426美元 vs 14,190美元,P < .001),且按成本类型、 census区域、症状状态和外科专科分层后差异仍显著。
要点
- CAS总住院成本显著高于CEA,无症状患者高40%,有症状患者高37%。
- 按固定成本、可变成本、区域和专科分层后,CAS成本优势仍一致。
- 不同专科医师行CAS的成本差异显著,血管外科、心脏外科和神经外科医师行CAS的成本均高于CEA。
核心结论
- 在匹配患者和医院特征后,CAS的总住院成本显著高于CEA,且不受症状状态、成本类型、医院区域和外科专科影响。
研究设计与样本
- 回顾性队列研究,使用Premier Perspective数据库2009年第三季度至2015年第一季度的出院和账单记录。
- 采用最近邻1:1倾向性评分匹配,使用32个变量匹配患者和医院特征及临床合并症,分别对有症状和无症状队列进行分析。
- 共识别115,548例手术,匹配后纳入无症状患者25,812例(CEA 12,906例,CAS 12,906例)和有症状患者3,864例(CEA 1,932例,CAS 1,932例)。
主要发现
- 无症状患者中,CAS总住院成本中位数为11,814美元,CEA为8,378美元,CAS高40%(P < .001)。
- 有症状患者中,CAS总住院成本中位数为19,426美元,CEA为14,190美元,CAS高37%(P < .001)。
- 无症状患者中,任何外科专科医师行CAS的总住院成本比CEA高2,717至4,918美元(所有P < .001)。
- 有症状患者中,血管外科医师行CAS比CEA高2,108美元(16,114美元 vs 14,006美元,P = .006),心脏外科医师高7,055美元(17,351美元 vs 10,296美元,P = .023),神经外科医师高6,479美元(27,290美元 vs 20,811美元,P = .002)。
临床怎么用
- 在考虑CAS适应证时,除临床结局外,应纳入住院成本差异的考量。
- CAS的总住院成本显著高于CEA,医疗决策者和支付方需关注此经济负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite multiple landmark clinical trials, little data exists on real-world cost of carotid artery stenting (CAS) and carotid endarterectomy (CEA) to the United States healthcare system. We aim to study differences in actual hospitalization cost between patients who underwent CAS vs CEA in a nationally representative database. METHODS: We studied hospital discharge and billing records of all patients, in the Premier Perspective Database, who underwent CEA or CAS between the third quarter of 2009 and the first quarter of 2015. Nearest-neighbor 1:1 propensity score matching was performed, to account for differences in patient and hospital characteristics as well as clinical comorbidities of patients who underwent both procedures, for both symptomatic and asymptomatic cohorts using 32 variables. Pearson χ2, Student t-test, and nonparametric K-sample equality-of-medians tests were used to analyze the data, as appropriate. The primary outcome was total in-hospital cost, including fixed (administrative, capital and utilities) and variable costs (labor and supply). Cost data were presented as medians, inflation-adjusted for 2015 U.S. dollar and rounded to the nearest dollar. RESULTS: A total of 115,548 procedures were identified. The mean age was 71 and 69 years; 58% and 57% were male patients; and 81% and 77% were white among asymptomatic and symptomatic patients, respectively. After propensity score matching, 25,812 asymptomatic (12,906 CEA and 12,906 CAS) and 3864 symptomatic (1932 CEA and 1932 CAS) patients were included. Total hospitalization cost per CAS was 40% ($11,814 vs $8378; P < .001) and 37% ($19,426 vs $14,190; P < .001) higher than CEA among asymptomatic and symptomatic patients, respectively. Patients who underwent CAS incurred significantly higher total hospitalization cost despite stratifying by type of cost (fixed and variable), U.S. census regions and symptomatic status. Moreover, asymptomatic patients who underwent CAS performed by any surgical specialty incurred an average of $2717 to $4918 higher total hospitalization cost compared with patients who underwent CEA (all P < 001). Among symptomatic patients, those who underwent CAS performed by vascular, cardiac, and neurologic surgeons, incurred $2108 ($16,114 vs $14,006; P = .006), $7055 ($17,351 vs $10,296; P = .023) and $6479 ($27,290 vs $20,811; P = .002) higher total hospitalization cost compared with patients who underwent CEA, respectively. CONCLUSIONS: The total hospitalization cost incurred by patients who underwent CAS was significantly higher than for those who underwent CEA, despite matching cohort based on patient and hospital characteristics, and stratifying by symptomatic status, type of cost, hospital region, and surgeon specialty. Our findings could provide additional important information giving the ongoing controversy regarding the appropriate indication for CAS.
引用
- Obeid T, Alshaikh H, Nejim B, et al. Fixed and variable cost of carotid endarterectomy and stenting in the United States: A comparative study. J Vasc Surg. 2017. PMID: 28216356. doi:10.1016/j.jvs.2016.11.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。